Kenfarb & Co’s Repligen RGEN Stock Holding History

Kenfarb & Co’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$111K	Hold	700	–	–	0.1%	122
2023 Q2	$99K	Hold	700	–	–	0.09%	127
2023 Q1	$118K	Hold	700	–	–	0.11%	119
2022 Q4	$119K	Hold	700	–	–	0.11%	119
2022 Q3	$131K	Hold	700	–	–	0.12%	111
2022 Q2	$132K	Hold	700	–	–	0.1%	115
2022 Q1	$132K	Hold	700	–	–	0.1%	115
2021 Q4	$185K	Buy	+700	New	+$189K	0.14%	107

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Kenfarb & Co's RGEN Position: Q3 2023 in Review

Kenfarb & Co held its Repligen (RGEN) position steady in Q3 2023 at 700 shares worth $111K. The position accounts for 0.1% of the portfolio, ranked #122.

Kenfarb & Co first reported a position in RGEN in Q4 2021 and has held it in 8 quarters since. The position peaked at $185K in Q4 2021. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

Kenfarb & Co held 700 shares of Repligen worth $111K as of Q3 2023.
Kenfarb & Co left its Repligen share count unchanged in Q3 2023.
Repligen made up 0.1% of Kenfarb & Co's portfolio in Q3 2023, its #122 holding.
Kenfarb & Co first reported a position in Repligen in Q4 2021 and has held it in 8 quarters since.
Kenfarb & Co's Repligen position peaked at $185K in Q4 2021.
439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.